Ans Punt

2.7k citations

75 papers · 1.9k indexed · h-index 27

Impact in

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment

Papers in ⓘ

Cancer Research 25
- Carcinogens and Genotoxicity Assessment 25
Health, Toxicology and Mutagenesis 23
- Effects and risks of endocrine disrupting chemicals 21

Co-authors: Ivonne M.C.M. Rietjens (44 shared papers)Peter J. van Bladeren (20 shared papers)Benoı̂t Schilter (13 shared papers)Thierry Delatour (9 shared papers)Bert Spenkelink (11 shared papers)Gabriele Scholz (12 shared papers)Marelle G. Boersma (10 shared papers)Jochem Louisse (9 shared papers)
Journals: Toxicological Sciences (8 papers)Chemical Research in Toxicology (8 papers)Toxicology in Vitro (7 papers)Archives of Toxicology (7 papers)Food and Chemical Toxicology (6 papers)
Partner nations: Netherlands Switzerland United States

In The Last Decade

Ans Punt

71 papers receiving 1.8k citations

Peers

Countries citing papers authored by Ans Punt

Since Specialization

Citations

This map shows the geographic impact of Ans Punt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ans Punt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ans Punt more than expected).

Fields of papers citing papers by Ans Punt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ans Punt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ans Punt. The network helps show where Ans Punt may publish in the future.

Co-authors

The 25 scholars most cited alongside Ans Punt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ans Punt Line = papers co-authored together Ans Punt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2 Biochemical Pharmacology ·Jelmer J. van Zanden, Heleen M. Wortelboer, Sabina Bijlsma, Ans Punt, Mustafa Usta, Peter J. van Bladeren, Ivonne M.C.M. Rietjens, Nicole H.P. Cnubben	2004	146
2	Impact of nanoparticle surface functionalization on the protein corona and cellular adhesion, uptake and transport Journal of Nanobiotechnology ·Ashraf Abdelkhaliq, Meike van der Zande, Ans Punt, Richard Helsdingen, Sjef Boeren, Jacques Vervoort, Ivonne M.C.M. Rietjens, Hans Bouwmeester	2018	80
3	A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat Toxicology and Applied Pharmacology ·Ans Punt, Andreas P. Freidig, Thierry Delatour, Gabriele Scholz, Marelle G. Boersma, Benoı̂t Schilter, Peter J. van Bladeren, Ivonne M.C.M. Rietjens	2008	71
4	Use of Physiologically Based Biokinetic (PBBK) Modeling to Study Estragole Bioactivation and Detoxification in Humans as Compared with Male Rats Toxicological Sciences ·Ans Punt, Alicia Paini, Marelle G. Boersma, Andreas P. Freidig, Thierry Delatour, Gabriele Scholz, Benoı̂t Schilter, Peter J. van Bladeren, Ivonne M.C.M. Rietjens	2009	68
5	Human Cytochrome P450 Enzyme Specificity for the Bioactivation of Estragole and Related Alkenylbenzenes Chemical Research in Toxicology ·S.M.F. Jeurissen, Ans Punt, Marelle G. Boersma, Jan J.P. Bogaards, Yiannis C. Fiamegos, Benoı̂t Schilter, Peter J. van Bladeren, Nicole H.P. Cnubben, Ivonne M.C.M. Rietjens	2007	67
6	Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose–response curves for developmental toxicity of phenol in rat and human Archives of Toxicology ·Marije Strikwold, Bert Spenkelink, R.A. Woutersen, Ivonne M.C.M. Rietjens, Ans Punt	2013	60
7	A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes Toxicology and Applied Pharmacology ·Alicia Paini, Ans Punt, Florian Viton, Gabriele Scholz, Thierry Delatour, Maricel Marin‐Kuan, Benoı̂t Schilter, Peter J. van Bladeren, Ivonne M.C.M. Rietjens	2010	59
8	Tutorial on physiologically based kinetic modeling in molecular nutrition and food research Molecular Nutrition & Food Research ·Ivonne M.C.M. Rietjens, Jochem Louisse, Ans Punt	2011	57
9	Tandem Mass Spectrometry Analysis of N²-(trans-Isoestragol-3‘-yl)-2‘-deoxyguanosine as a Strategy to Study Species Differences in Sulfotransferase Conversion of the Proximate Carcinogen 1‘-Hydroxyestragole Chemical Research in Toxicology ·Ans Punt, Thierry Delatour, Gabriele Scholz, Benoı̂t Schilter, Peter J. van Bladeren, Ivonne M.C.M. Rietjens	2007	56
10	Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1′-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells Food and Chemical Toxicology ·S.M.F. Jeurissen, Ans Punt, Thierry Delatour, Ivonne M.C.M. Rietjens	2008	46
11	Conversion of major soy isoflavone glucosides and aglycones in in vitro intestinal models Molecular Nutrition & Food Research ·Mohammed Ariful Islam, Ans Punt, Bert Spenkelink, Albertinka J. Murk, F.X.R. van Leeuwen, Ivonne M.C.M. Rietjens	2013	46
12	Development of a Web-Based Toolbox to Support Quantitative In-Vitro-to-In-Vivo Extrapolations (QIVIVE) within Nonanimal Testing Strategies Chemical Research in Toxicology ·Ans Punt, Nicole Pinckaers, Ad Peijnenburg, Jochem Louisse	2020	46
13	Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect Toxicology and Applied Pharmacology ·Wasma Alhusainy, Alicia Paini, Ans Punt, Jochem Louisse, A. Spenkelink, Jacques Vervoort, Thierry Delatour, Gabriele Scholz, Benoı̂t Schilter, Timothy B. Adams, Peter J. van Bladeren, Ivonne M.C.M. Rietjens	2010	45
14	Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I Food and Chemical Toxicology ·Rozaini Abdullah, Wasma Alhusainy, Jasper Woutersen, Ivonne M.C.M. Rietjens, Ans Punt	2016	42
15	New approach methodologies (NAMs) for human-relevant biokinetics predictions ALTEX ·Ans Punt	2020	41
16	Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4) Archives of Toxicology ·Jochem Louisse, Luca Dellafiora, Jeroen J. M. W. van den Heuvel, Deborah Rijkers, Liz Leenders, J.L.C.M. Dorne, Ans Punt, Frans G. M. Rüssel, Jan B. Koenderink	2022	41
17	Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols Archives of Toxicology ·Marije Strikwold, Bert Spenkelink, Laura H.J. de Haan, R.A. Woutersen, Ans Punt, Ivonne M.C.M. Rietjens	2016	38
18	Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat Toxicology and Applied Pharmacology ·Ala’ Ali Ahmad Al-Subeihi, Bert Spenkelink, Ans Punt, Marelle G. Boersma, Peter J. van Bladeren, Ivonne M.C.M. Rietjens	2012	38
19	Non-animal approaches for toxicokinetics in risk evaluations of food chemicals ALTEX ·Ans Punt	2017	36
20	In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: Implications for risk assessment Molecular Nutrition & Food Research ·Ivonne M.C.M. Rietjens, Ans Punt, Benoı̂t Schilter, Gabriele Scholz, Thierry Delatour, Peter J. van Bladeren	2009	36

About Ans Punt

Ans Punt is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis, Pharmacology, Molecular Biology and Small Animals, having authored 75 papers that have together received 1.9k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (25 papers), Effects and risks of endocrine disrupting chemicals (21 papers), Pharmacogenetics and Drug Metabolism (17 papers), Animal testing and alternatives (11 papers), Computational Drug Discovery Methods (9 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Drug Transport and Resistance Mechanisms (6 papers) and Phytochemicals and Antioxidant Activities (5 papers). The work is most often cited by research in Pharmacology (390 citations), Cancer Research (501 citations), Health, Toxicology and Mutagenesis (429 citations), Small Animals (183 citations) and Food Science (344 citations). Ans Punt has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Ivonne M.C.M. Rietjens, Peter J. van Bladeren, Benoı̂t Schilter, Thierry Delatour, Bert Spenkelink, Gabriele Scholz, Marelle G. Boersma, Jochem Louisse, A. Spenkelink and Alicia Paini. Their work appears in journals such as Toxicological Sciences, Chemical Research in Toxicology, Toxicology in Vitro, Archives of Toxicology and Food and Chemical Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact